BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31382203)

  • 1. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A.
    Zhang Y; Li A; Huang CL; Wang G; Wang D
    Stem Cell Res; 2019 Aug; 39():101509. PubMed ID: 31382203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-specific induced pluripotent stem cell properties implicate Ca
    Zhou Y; Huang W; Liu L; Li A; Jiang C; Zhou R; Wang J; Tan X; Huang CL; Zhang Y
    Philos Trans R Soc Lond B Biol Sci; 2023 Jun; 378(1879):20220175. PubMed ID: 37122207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cells (iPSCs) from a Chinese infant (XACHi015-A) with type 2 Long QT syndrome carrying the heterozygous mutation c.1814C>T(p.P605L) in KCNH2.
    Wang T; Zhou Y; Zhou R; Huang W; Wang J; Li H; Lei M; Tan X; Zhang Y
    Stem Cell Res; 2021 Oct; 56():102509. PubMed ID: 34438161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy.
    Ross SB; Fraser ST; Bagnall RD; Semsarian C
    Stem Cell Res; 2017 Apr; 20():76-79. PubMed ID: 28395744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells.
    Gao Y; Cheng Y; Wen J; Xiao D; Xu J; Cai C; Hu J
    Stem Cell Res; 2023 Jun; 69():103088. PubMed ID: 37099933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
    Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
    Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene.
    Ross SB; Fraser ST; Nowak N; Semsarian C
    Stem Cell Res; 2017 Apr; 20():88-90. PubMed ID: 28395747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of induced pluripotent stem cells (iPSCs) from an infant with Pompe disease carrying with compound mutations of R608X and E888X in GAA gene.
    Zhang Y; Li A; Wang J; Wang G; Wang D
    Stem Cell Res; 2019 Dec; 41():101621. PubMed ID: 31743840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of three iPSC lines (XACHi007-A, XACHi008-A, XACHi009-A) from a Chinese family with long QT syndrome type 5 with heterozygous c.226G>A (p.D76N) mutation in KCNE1gene.
    Zhang Y; Li H; Wang J; Wang G; Tan X; Lei M
    Stem Cell Res; 2020 May; 45():101798. PubMed ID: 32344329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of human induced pluripotent stem cell lines from three patients affected by Catecholaminergic Polymorphic ventricular tachycardia (CPVT) carrying heterozygous mutations in RYR2 gene.
    Cimarosti B; Canac R; De Waard S; Girardeau A; Gaignerie A; Derevier A; Forest V; Ronjat M; Le Marec H; Gourraud JB; Lemarchand P; De Waard M; Lamirault G; Gaborit N
    Stem Cell Res; 2022 Apr; 60():102688. PubMed ID: 35101670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of a human iPSC line SANi005-A containing the gray platelet associated heterozygous mutation p.Q287* in GFI1B.
    Hansen M; Varga E; Wüst T; Mellink C; van der Kevie-Kersemaekers AM; Marneth AE; von Lindern M; van der Reijden B; van den Akker E
    Stem Cell Res; 2017 Dec; 25():34-37. PubMed ID: 29055225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
    Ye H; Wang Q
    Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female.
    Nimonkar MM; Arunachal G; Dash SS; Kandy SK; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
    Stem Cell Res; 2023 Aug; 70():103130. PubMed ID: 37269666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human induced pluripotent stem cells (EURACi001-A, EURACi002-A, EURACi003-A) from peripheral blood mononuclear cells of three patients carrying mutations in the CAV3 gene.
    Meraviglia V; Benzoni P; Landi S; Murano C; Langione M; Motta BM; Baratto S; Silipigni R; Di Segni M; Pramstaller PP; DiFrancesco D; Gazzerro E; Barbuti A; Rossini A
    Stem Cell Res; 2018 Mar; 27():25-29. PubMed ID: 29304398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors.
    Vlahos K; Sourris K; Yi Kuah J; Graham A; Suter A; Howden SE; Stanley EG; Elefanty AG
    Stem Cell Res; 2023 Jun; 69():103109. PubMed ID: 37150143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of induced pluripotent stem cell line SDPHi003-A from a healthy male donor.
    Xi Y; Zhang H; Yang X; Ai D; Liu Y; Song W
    Stem Cell Res; 2023 Sep; 71():103160. PubMed ID: 37429069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
    Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
    Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of two induced pluripotent stem cell lines (XACHi0010-A, XACHi0011-A) from a Chinese family with combined oxidative phosphorylation deficiency carrying homozygous and heterozygous C1QBP-L275F mutation.
    Zhang Y; Wang J; Zhou Y; Li H; Li A; Tan X; Wang G; Lei M
    Stem Cell Res; 2020 Jul; 47():101912. PubMed ID: 32707487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene.
    Lopez-Onieva L; Montes R; Lamolda M; Romero T; Ayllon V; Lozano ML; Vicente V; Rivera J; Ramos-Mejía V; Real PJ
    Stem Cell Res; 2016 May; 16(3):692-5. PubMed ID: 27346198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.